Thank you for reaching out.
We’ll get back to you shortly.

Thank you for reaching out.
We’ll get back to you shortly.

Contact Us

How oligodendrocytes may shape autism

About a decade ago, Carlos Parras started to suspect that autism researchers had overlooked something important — a peculiarly shaped cell called an oligodendrocyte.

Most autism research focused on neurons, the cells that make up the bulk of the brain and exchange signals with one another and the rest of the body. But Parras, a researcher at the Paris Brain Institute in France, had an inkling that oligodendrocytes — support cells that generate the electrical insulation around neurons’ long projections, or axons — deserved greater attention.

He decided to study how CHD8 — the gene most frequently mutated in autistic people — and its cousin, CHD7, specifically affect these cells.

Parras and his colleagues created mice missing either gene only in their oligodendrocytes. The CHD8 mice had intense seizures, not unlike those seen in some people with autism, and they died within a few weeks. The animals’ brains, it seemed, couldn’t regulate electrical activity.

Parras’ work is part of a growing body of evidence showing that genes strongly linked to autism, including CHD8, NLGN3, PTEN and SCN2A, contribute to the development and function of oligodendrocytes — and that these cells may play a larger role in autism than previously thought.

As the findings accumulate, they are upending long-held views about which brain cells are involved in autism, researchers say.

“Many people are shifting from neuron biology to oligodendrocyte dysfunction,” says Keiichi Nakayama, professor of molecular and cellular biology at Kyushu University in Fukuoka, Japan, who published the first behavioral observations of CHD8 mice.

And because oligodendrocytes are masters of plasticity — the brain’s ability to change in response to its environment — understanding these cells could ultimately lead to improved therapies for people with autism, researchers say.

“The thing people are trying to understand is how much neurons are important for autism, how much oligodendrocytes are also important for autism, and how much is the interaction between the two,” Parras says.

Wrapped attention:

Most neurons form in utero, but oligodendrocytes — like other non-neuronal, or ‘glial,’ cells — develop after birth and continue to form throughout early adulthood.

They make up 5 to 10 percent of the brain’s cells, are found predominantly in ‘white matter,’ and have one key function: to create myelin. This mix of fats and proteins sheaths axons much like rubber insulation on a wire. The coating enables the smooth transfer of electrical signals throughout the brain and gives white matter its characteristic color.

But oligodendrocytes are not static myelin factories. Those located near synapses can respond to neuronal chatter. They can also produce more myelin, or slow down production, in response to environmental factors, including social stimuli.

For example, mouse pups isolated soon after birth have a shortage of myelin in the medial prefrontal cortex, a brain area associated with social activity, according to a 2012 study. They also have little interest in socializing with other animals. And mice missing a gene that regulates myelination show similarly curtailed sociability, even when they are not isolated.

At around the same time as those animal experiments, other teams found that white matter in autistic people tends to differ from that of non-autistic people, and that several autism-linked genes seem to regulate myelination. Taken together, the observations prompted some researchers to explore oligodendrocytes’ role in autism, says Jun Hee Kim, associate professor of cellular and integrative physiology at the University of Texas Health Science Center at San Antonio.

three MRIs with the corpus callosum highlighted by red arrows

Low volume: Autistic children with CHD8 mutations (middle and right) have less cerebral white matter than non-autistic children (left).

Kim became interested in the cells through SCN2A. The autism-linked gene codes for part of a sodium ion channel expressed in both neurons and oligodendrocytes. In 2017, she says, she was surprised to discover that some immature oligodendrocytes containing these channels generate electrical spikes. What’s more, blocking the channel in the cells leads to a shortage of myelination in the auditory brainstem.

“This would strongly indicate that SCN2A is important for electrical excitability in oligodendrocytes,” she says — which, in turn, may be important for the cells’ ability to communicate with neurons and make myelin.

In the auditory system, for example, cross-talk between oligodendrocytes and neurons may be essential for controlling how the brain processes incoming sounds — a process Kim calls a “black box.” SCN2A might be one key “wire” inside the black box, she says, mediating the creation of myelin needed to transmit auditory information throughout the brain. Kim is investigating whether mice lacking SCN2A have sound-processing difficulties similar to those seen in some people with autism.

“The neuron-glia interaction is one of the key elements for control[ling] this myelin plasticity in autism or in brain development,” Kim says.

Myelin mediated:

Similar patterns have emerged for PTEN, an autism-linked gene that regulates cell division. Autistic people with mutations in PTEN have more white matter than other autistic people and non-autistic people — findings that prompted Charis Eng, chair and director of the Cleveland Clinic’s Genomic Medicine Institute in Ohio, to explore the gene’s connection to oligodendrocyte development and function in mice.

Mice with some PTEN mutations have a thickened corpus callosum — the white matter bundle connecting the brain’s hemispheres — and an excess of ‘precursor’ cells that grow into oligodendrocytes, Eng has found. Those cells also mature unusually quickly and sometimes dump myelin next to axons, rather than encasing them. Whether these structural differences in the brain can contribute to autism-like behaviors is worth investigating, she says.

“Our work and the work of other labs over the past decade justifies increased focus on the effects of glia dysfunction on behavior,” Eng says.

More clues that changes to oligodendrocyte function can affect behavior come from mice missing a copy of CHD8, created in Nakayama’s lab. These animals have a thinner myelin sheath around their axons and larger gaps between myelinated areas than control mice do, according to a study published last year. The gaps seem to slow down electrical signals.

The mice also have autism-like behaviors: They show less interest in a new mouse than controls do, and they interact with a companion mouse less, though they spend more time huddled close to one another. They also spend less time in a well-lit chamber — mice prefer the dark —indicating heightened anxiety levels.

Mice missing CHD8 only in their oligodendrocytes show similar traits, Nakayama and his colleagues have found. The mice also have structural changes in the cortex and striatum and altered functional connectivity in the cortex, hippocampus and amygdala, compared with controls — and the extent of these structural differences reflects their behavioral differences.

“Our conclusion is that CHD8 function in oligodendrocytes is very important for [autism],” Nakayama says. “Oligodendrocyte dysfunction might be the primary cause.”

Mice missing CHD8 throughout their bodies show more autism-like traits, including higher brain volume, than those missing CHD8 only in their oligodendrocytes. But other cells, such as neurons, may be responsible for those differences, Nakayama says.

“It’s a very good demonstration that at least part of the function of this gene related to autism goes through myelination,” Parras says of Nakayama’s work.

Myelination, black and white micrograph

Bridge building: Mice with CHD8 mutations only in their oligodendrocytes (right) have less myelination in their corpus callosum than mice without the mutations (left).

Open window:

Some gene sequencing studies tie autism-linked genes to oligodendrocyte function, too. Mutations in 35 autism-linked genes affect the function of glial cells, including oligodendrocytes, in mice, according to work published in November. And the expression of genes related to oligodendrocyte function is decreased more than that of genes related to other cells in mice missing one copy of CHD8 and in the brains of people with autism.

Mice with mutations in PTEN, MECP2 or TCF4 also have altered expression of genes involved in oligodendrocyte function, and those same genes show atypical expression in people with autism.

The connection between oligodendrocytes and autism, though still tenuous, holds significant promise, researchers say. If future studies reinforce findings from the past decade, drugs that boost oligodendrocyte function and promote myelination — some of which are being developed for conditions such as multiple sclerosis — could serve as a treatment for some autistic people, Parras says. And because oligodendrocytes develop across so many years, there may be a broad time period in which therapies targeted at the cells are effective.

But first, researchers need to understand the connection more precisely, he says.

“The more we go into the details, the more we realize that those windows of intervention can be deployed in longer periods,” Parras says. “We need to know very well the details to be able to change things.”

The post How oligodendrocytes may shape autism appeared first on Spectrum | Autism Research News.

related articles

User Pic

Sensory issues linked to heart-rate differences in autistic youth

Autistic children with sensory issues show more intense physiological reactions to unpl...

User Pic

New macaque reference genome fills sequence gaps

Researchers have created the most complete macaque reference genome to date and used it...

User Pic

Webinar: André Fenton on rethinking dysfunction in fragile X model mice

Register for the next Spectrum webinar, featuring André Fenton, who will speak about re...


google analytics policy

we may collect information about your computer, including your IP address, operating system and browser type, for system administration and in order to create reports. This is statistical data about our users' browsing actions and patters, and does not identify any individual.

The only cookies in use on our site are for Google Analytics. Google Analytis is aweb analytics tool that helps website owners understand how visitors engage with their website. GoogleAnalytics customers can view a variety of reports about how visitors interact with their website so that they can improve it.

Like many services, Google Analytics users first-party cookies to track visitor interactions as in our case, where they are used to collect information about how visitors use our site. We then use the information to compile reports and to help use improve our site.

Cookies contain information that is transferred to your computer's hard drive. These cookies are used to store information, such as the time that the current visit occured, whether the visitor has been to the site before and what site referred the visitor to the web page.

Google Analyticsw collets information anonymously. It reports website trends without identifying individual visitors. you can opt out of Google Analytics without affecting how your visit our site- for more information on opting our of being tracked by Google Analytics across all websites you use, visit this Google page


hipaa privacy

Compleat KiDZ


If you have any questions about this Notice of Privacy Practices, please contact our Privacy Officer, by telephone at (704) 824-7800 or in writing at 2675 Court Drive, Gastonia, NC 28054.
This Notice of Privacy Practices describes how we may use and disclose your protected health information to carry out treatment, payment or health care operations and for other purposes that are permitted or required by law. It also describes your rights to access and control your protected health information. Protected health information is information about you, including demographic information, that may identify you and that relates to your past, present or future physical or mental health or condition and related health care services.


We are required to abide by the terms of this Notice of Privacy Practices. We may change the terms of our Notice of Privacy Practices at any time. The new Notice of Privacy Practices will be effective for all protected health information that we maintain at that time. Upon your request, we will provide you with any revised Notice of Privacy Practices. You may request a revised version by calling or writing our Privacy Officer and requesting that a revised copy be sent to you in the mail or asking for one at the time of your next appointment.


Your protected health information may be used and disclosed by our office staff others outside of our office who are involved in your care and treatment for the purpose of providing health care services to you.
Your protected health information may also be used and disclosed to pay your health care bills and to support the operation of our practice.
Following are examples of the types of uses and disclosures of your protected health information that we are permitted to make. These examples are not meant to be exhaustive, but to describe the types of uses and disclosures that may be made by our office.

1. Treatment: We will use and disclose your protected health information to provide, coordinate, or manage your health care and any related services. This includes the coordination or management of your health care with another provider.
For example, we would disclose your protected health information, as necessary, to a home health agency that provides care to you. We will also disclose protected health information to other healthcare providers who may be treating you.
For example, your protected health information may be provided to a physician to whom you have been referred to ensure that the physician has the necessary information to diagnose or treat you. In addition, we may disclose your protected health information from time-to-time to other health care providers (e.g., a specialist or laboratory) who become involved in your care by providing assistance with your health care diagnosis or treatment to us.
2. Payment: We may use and disclose protected health information about you so that the treatment and services you receive at Compleat KiDZ may be billed to and payment may be collected from you, an insurance company, or a third party. This may include certain activities that your health insurance plan may undertake before it approves or pays for the health care services we recommend for you such as: making a determination of eligibility or coverage for insurance benefits, and reviewing services provided to you for medical necessity. For example, if you have a back injury, we may need to give your health plan information about your condition, supplies used, and services you received.
3. Healthcare Operations: We may use or disclose, as needed, your protected health information for healthcare operations. These uses and disclosures are necessary to run Compleat KiDZ and make sure that all of our patients receive quality care. For example, we ma)'use protected health information to review our treatment and services and to evaluate the performance of our staff in caring for you. We may also combine protected health information about many patients to decide what additional services Compleat KiDZ should offer, what services are not needed, and whether certain new treatments are effective. We may also disclose information to doctors, nurses, technicians, medical students, and other personnel for review and learning purposes, we may remove information that identifies you from this set of protected health information so others may use it to study health care and health care delivery without learning the identities of specific patients.
We may share your protected health information with third party "business associates" that perform various activities (for example, billing or transcription services) for our practice. Whenever an arrangement between our practice and a business associate involves the use or disclosure of your protected health information, we will have a written contract that contains terms that will protect the privacy of your protected health information.
We may use and / or disclose protected health information to contact you to, remind you about an appointment you have for treatment or medical care.
We may use or disclose your protected health information, as necessary, to provide you with information about treatment alternatives or other health--related benefits and services that may be of interest to you. You may contact our Privacy Officer to request that these materials not be sent to you.
4. Other Permitted and Required Uses and Disclosures That May Be Made Without Your Authorization or Opportunity to Agree and Object:
We may use or disclose your protected health information in the following situations without your authorization or providing you the opportunity to agree or object. These situations include:
(i) Required by Law: We may use or disclose your protected health information to the extent that the use or disclosure is required by law. The use or disclosure will be made in compliance with the law and will be limited d to the relevant requirements of the law. You will be notified, if required by law, of any such uses or disclosures.

(ii) Public Health: We may disclose your protected health information for public health activities and purposes to a public health authority that is permitted by law to collect or receive the information. For example, a disclosure may be made for the purpose of preventing or controlling disease, injury or disability.

(iii) Communicable Diseases: We may disclose your protected health information, if authorized by law, to a person who may have been exposed to a communicable disease or may otherwise be at risk of contracting or spreading the disease or condition.

(iv) Health Oversight: We may disclose protected health information to a health oversight agency for activities authorized by law, such as audits, investigations, and inspections. Oversight agencies seeking this information include government agencies t-rat oversee the health care system, government benefit programs, other government regulatory programs and civil rights laws.

(v) Abuse or Neglect: We may disclose your protected health information to a public health authority that is authorized by law to receive reports of child abuse or neglect. In addition, we may disclose your protected health information if we believe that you have been a victim of abuse, neglect or domestic violence to the governmental entity or agency authorized to receive such information. In this case, the disclosure will be made consistent with the requirements of applicable federal and state laws.

(vi) Legal Proceedings: We may disclose protected health information in the course of any judicial or administrative proceeding, in response to an order of a court or administrative tribunal (to the extent such disclosure is expressly authorized), or in certain conditions in response to a subpoena, discovery request or other lawful process.

(vii) Law Enforcement: We may also disclose protected health information, so long as applicable legal requirements are met, for law enforcement purposes, these law enforcement purposes include (1) legal processes and otherwise required by law, (2) limited information requests for identification and location purposes, (3) pertaining to victims of a crime, (4) suspicion that death has occurred as a result of criminal conduct, (5) in the event that a crime occurs on the premises of our practice, and (6) medical emergency (not on our premises) and it is likely that a crime has occurred.

(viii) Research: We may disclose your protected health information to researchers when their research has been approved by an institutional review board that has reviewed the research proposal and established protocols to ensure the privacy of your protected health information.

(ix) Criminal Activity: Consistent with applicable federal and state laws, we may disclose your protected health information, if we believe that the use or disclosure is necessary to prevent or lessen a serious and imminent threat to the health or safety of a person or the public. We may also disclose protected health information if it is necessary for law enforcement authorities to identify or apprehend an individual.

(x) Military Activity and National Security: When the appropriate conditions apply, we may use or disclose protected health information of individuals who are Armed Forces personnel (1) for activities deemed necessary by appropriate military command authorities; (2) for the purpose of a determination by the Department of Veterans Affairs of your eligibility for benefits, or (3) to foreign military authority if you are a member of that foreign military services. We may also disclose your protected health information to authorized federal officials for conducting national security and intelligence activities, including for the provision of protective services to the President or others legally authorized.

(xi) Workers' Compensation: We may disclose your protected health information as authorized to comply with workers' compensation laws and other similar legally established programs.
5. Other Permitted and Required Uses of Disclosures That Require Providing You the Opportunity to Agree or Object
We may use and disclose your protected health information in the following instances. You have the opportunity to agree or object to the use or disclosure of all or part of your protected health information. If you are not present or able to agree or object to the use or disclosure of the protected health information, then we may, using professional judgment, determine whether the disclosure is in your best interest.

Others Involved in Your Health Care or Payment for our Care:

Unless you object, we may disclose to a member of your family, a relative, a close friend or any other person you identify, your protected health information that directly relates to that person's involvement in your health care. If you are unable to agree or object to such a disclosure, we may disclose such information as necessary if we determine that it is in your best interest based on our professional judgment. We may use or disclose protected health information to notify or assist in notifying a family member, personal representative or any other person that is responsible for your care of your location, general condition or death. Finally, we may use or disclose your protected health information to an authorized public or private entity to assist in disaster relief efforts and to coordinate uses and disclosures to family or other individuals involved in your health care.
6. Uses and Disclosures of Protected Health Information Based upon Your Written Authorization Other uses and disclosures of your protected health information will be made only with your written authorization, unless otherwise permitted or required by law as described below. You may revoke this authorization in writing at any time. If you revoke your authorization, we will no longer use or disclose your protected health information for the reasons covered by your written authorization. Please understand that we are unable to take back any disclosures already made with your authorization.
Following is a statement of your rights with respect to your protected health information and a brief description of how you may exercise these rights
1. You have the right to inspect and copy your protected health information
This means you may inspect and obtain a copy of protected health information about you for so long as we maintain the protected health information. You may obtain your medical record that contains medical and billing records and any other records that we use for making decisions about you. As permitted by federal or state law, we may charge you a reasonable copy fee for a copy of your records.
2. You have the right to request a restriction of your protected health information
This means you may ask us not to use or disclose any part of your protected health information for the purposes of treatment, payment or health care operations. You may also request that any part of your protected health information not be disclosed to family members or friends who may be involved in your care or for notification purposes as described in this Notice of Privacy Practices. Your request must state the specific restriction requested and to whom you want the restriction to apply.

We are not required to agree to a restriction that you may request. If we agree to the requested restriction, we may not use or disclose your protected health information in violation of that restriction unless it is needed to provide emergency treatment. With this in mind, please discuss any restriction you wish to request with your health provider.

You may request a restriction by making your request in writing to our Privacy Officer. In your request, you must tell us (1) what information you want to limit; (2) whether you want to limit our use, disclosure, or both; and (3) to whom you want the limits to apply, for example, disclosures to your spouse.
3. You have the right to request to receive confidential communications from us by alternative means or at an alternative location
We will accommodate reasonable requests. We may also condition this accommodation by asking you for information as to how payment will be handled or specification of an alternative address or other method of contact. We will not request an explanation from you as to the basis for the request. Please make this request in writing to our Privacy Officer.
4. Your may have right to amend your protected health information
This means you may request an amendment of protected health information about you in a designated record set for so long as we maintain this information. In certain cases, we may deny your request for an amendment. If we deny your request for amendment, you have the right to file a statement of disagreement with us and we may prepare a rebuttal to your statement and will provide you with a copy of any such rebuttal. Please contact our Privacy Officer if you have questions about amending your medical record.
5. You have the right to receive an accounting of certain disclosures we have made, if any, of your protected health information This right applies to disclosures for purposes other than treatment, payment or health care operations as described in this Notice of Privacy Practices. It excludes disclosures we may have made to you if you authorized us to make the disclosure, to family members or friends involved in your care, or for notification purposes, for national security or intelligence, to law enforcement (as provided in the privacy rule) or correctional facilities, as part of a limited data set disclosure. The right to receive this information is subject to certain exceptions, restrictions and limitations.
6. You have the right to obtain a paper copy of this notice from us
upon request, even if you have agreed to accept this notice electronically.
You may complain to us or to the Secretary of Health and Human Services if you believe your privacy rights have been violated by us. You may file a complaint with us by notifying our Privacy Officer of your complaint. We will not retaliate against you for filing a complaint

You may contact our Privacy Officer at (704) 824-7800 for further information about the complaint process.

This notice was published and becomes effective on August l, 2011.